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Objective:  This study was performed to assess the long-term outcome of untreated
mild aortic valve disease present at the time of initial mitral valve intervention.
Methods:  A total of 284 patients with rheumatic heart disease aged 7 to 62 years
(mean, 23.5 ± 12.2 years) who underwent mitral valve intervention and had mild
aortic valve disease initially were followed up for 2 to 18 years (mean, 10.8 ± 3.7
years). At initial intervention, 232 patients had pure mild aortic regurgitation, and
52 patients had mild aortic stenosis with or without aortic regurgitation.
Results:  Among patients with mild aortic regurgitation initially, 11 (5%) patients
progressed to moderate (n = 6) or severe (n = 5) regurgitation over an interval of 9
to 17 years (mean, 12.1 ± 2.8 years), and 1 patient had moderate aortic stenosis and
severe aortic regurgitation after 10 years. Freedom from development of moderate-
severe aortic valve disease in patients who initially had mild aortic regurgitation
was 100%, 97.0% ± 1.7%, and 87.4% ± 4.6% at 5, 10, and 15 years, respectively.
Seventeen (35%) patients with initial mild aortic stenosis (with or without regurgi-
tation) had moderate or severe stenosis (with or without moderate-severe regurgita-
tion) after an interval of 4.9 ± 3.8 years. Freedom from development of moderate-
severe aortic valve disease in patients who initially had mild aortic stenosis was
75.6% ± 6.2%, 61.5% ± 8.5%, and 46.1% ± 11.2% at 5, 10, and 15 years, respec-
tively. Ten patients required aortic valve replacement for aortic valve dysfunction.
Conclusions:  Mild aortic regurgitation present at the time of mitral valve interven-
tion progresses very slowly and less frequently requires reintervention. However,
mild aortic stenosis diagnosed initially progresses more often and more rapidly and
thus needs closer follow-up.
In a significant proportion of patients with rheumatic heart disease, boththe aortic and the mitral valves are involved.1 If both valves are severelydiseased, the management is simple. The problem arises when one of thevalves is diseased only mildly and may not need any intervention if pre-sent in isolation. Such a dilemma is frequently encountered at the time ofthe mitral valve operation, when the aortic valve is found to be mildly
diseased.2 We reviewed our experience over the last 20 years with patients who
underwent a mitral valve procedure and had mild aortic valve disease at initial
presentation.
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Patients and Methods
From January 1979 through December 1997, 5274 patients under-
went isolated mitral valve procedure. Patients who underwent preop-
erative cardiac catheterization-cineangiography were selected. Of
these, 412 patients had mild aortic valve disease, as diagnosed with
cineangiography-cardiac catheterization. Patients with inadequate
follow-up (<2 years) and patients who died either early (≤1 month)
postoperatively or who within 2 years of the operation, primarily
because of mitral prosthetic dysfunction, anticoagulation-related
hemorrhage, or ventricular dysfunction, were excluded from the
study. Similarly, patients who had preoperative left ventricular dys-
function (ejection fraction < 50%) or patients who had left ventricu-
lar dysfunction postoperatively were also excluded from the study.
Patients having significant coronary artery disease at the time of ini-
tial diagnosis were also not included. Thus, a total of 284 patients
were included in the study. Hospital records for these patients were
carefully scrutinized. The demographic and clinical profile of the
study group is shown in the Table 1.
Before the mitral valve procedure, all these 284 patients under-
went cineangiography and cardiac catheterization. Peak-to-peak gra-
dients across the aortic valve were measured by the pull-back tech-
nique. Peak gradients of less than 25 mm Hg across the aortic valve
were considered as mild AS. AR was qualitatively assessed on a scale
of +1 to +4.3 AR with grade +1 was considered of mild severity.
Ejection fraction was calculated by the single-plane formula4 or
echocardiography. Mild AS was present in 18 patients, and mild AR
was observed in 232 patients. Mixed stenosis and regurgitation was
present in 34 patients.
These patients underwent different mitral valve procedures,
including mitral valve replacement (n = 154), mitral valve repair (n =
48), open mitral commissurotomy (n = 38), closed mitral valvotomy
(n = 16), and balloon mitral valvotomy (n = 28).
Follow-up was assessed with either cardiac catheterization-
cineangiography (n = 108) or, more recently, echocardiography (n =
176). On echocardiography, peak and mean transvalvular gradients
were calculated with the Bernoulli equation by continuous-wave
Doppler echocardiography.5 Mean gradient across the aortic valve
was used to define the severity of AS (mild ≤ 25 mm Hg; moderate
25-50 mm Hg; and severe > 50 mm Hg). In the absence of mean gra-
dient, peak gradients (≥50 mm Hg and ≥75 mm Hg) across the aor-
tic valve were considered as moderate and severe AS. AR was grad-
ed according to published criteria as mild (grade I/II), moderate
(grade III), and severe (grade IV).6 Moderate-severe AS or AR was
considered significant aortic valve disease.
Continuous or interval-related variables were expressed as mean
values ± standard deviation. Categorical variables were expressed as
percentages. Groups were compared by χ2 analysis and t tests.
Actuarial estimates were calculated and compared by the Kaplan-
Meier technique with log-rank tests.7 Cox proportional hazard regres-
sion was used to analyze a number of variables for development of
significant aortic valve disease in follow-up. These included age, sex,
functional class, rhythm, diabetes mellitus, hypertension, smoking,
hyperlipedemia, predominant mitral valve lesion (stenosis, regurgita-
tion, or mixed), initial aortic valve lesion (stenosis or regurgitation),
and type of mitral valve intervention. For the purpose of analysis,
patients having mild AS with or without mild AR were considered in
a single group. All statistical analysis was performed with the SPSS
for Windows 6.0 software package (SPSS Inc, Chicago, Ill).
Results
Follow-up ranged from 2 to 18 years (mean, 10.8 ± 3.7 years).
There were 29 late deaths caused by congestive heart failure (n
= 9), prosthetic valve dysfunction (n = 5), anticoagulant-relat-
ed hemorrhage (n = 3), cerebrovascular accident (n = 4), and
noncardiac causes (n = 8).
In 29 patients aortic valve disease progressed to significant
severity. In patients with mild AR initially, 11 (5%) patients
progressed to significant AR (moderate AR in 6 and severe AR
in 5) over an interval of 9 to 17 years (mean, 12.1 ± 2.8 years).
An additional patient with mild AR initially had moderate AS
and severe AR after a follow-up of 10 years. Freedom from
development of moderate-severe aortic valve disease in
patients who initially had mild AR was 100%, 97.0% ± 1.7%,
and 87.4% ± 4.6% at 5, 10, and 15 years, respectively.
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TABLE 1. Demographic and clinical profile of patients (n =
284)
Variable
Age (y)
Range 7-62
Mean ± SD 23.5 ± 12.2
Sex
Male/female 153/131
Predominant mitral lesion
Stenosis 167 (59%)
Regurgitation 71 (25%)
Mixed 46 (16%)
NYHA class III/IV 268 (94%)
Congestive heart failure 71 (25%)
Atrial fibrillation 147 (52%)
Previous procedure
Closed mitral valvotomy 26 (9%)
Balloon mitral valvotomy 8 (3%)
Diabetes mellitus 8 (3%)
Hypertension 10 (4%)
SD, Standard deviation; NYHA, New York Heart Association.
TABLE 2. Details of reoperation
Previous procedure Reoperation No.
Mitral valve replacement Mitral valve replacement 2*
Aortic valve replacement 4
Mitral valve repair Mitral valve replacement 2
Double-valve replacement 2
Open mitral commissurotomy Mitral valve replacement 2
Double-valve replacement 1
Closed mitral valvotomy Mitral valve replacement 4
Double-valve replacement 2
Balloon mitral valvotomy Mitral valve replacement 3
Double-valve replacement 1
*Indications included valve thrombosis in 1 patient and paravalvular leak
in another.
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Among patients who had mild AS initially, 7 patients had
significant AS (moderate AS in 4 and severe AS in 3) after a
follow-up of 1 to 12 years (mean, 4.9 ± 4.2 years). Ten patients
who had both mild AS and AR initially had significant aortic
valve disease after a follow-up of 1 to 13 years (mean, 4 ± 3.5
years). This included severe AS (n = 1), moderate AS (n = 2),
and combined moderate-severe AS and moderate-severe AR
(n = 7). Thus, 17 (35%) patients with initial AS (with or with-
out mild AR) progressed to significant disease over a duration
of 1 to 13 years (mean, 4.9 ± 3.8 years). Freedom from devel-
opment of moderate-severe aortic valve disease in patients
who initially had mild AS was 75.6% ± 6.2%, 61.5% ± 8.5%,
and 46.1% ± 11.2% at 5, 10, and 15 years, respectively. It was
significantly less (P < .001) than those who had only mild AR
initially (Figure 1). Similarly, the average duration for pro-
gression of aortic valve disease was significantly less in
patients who had mild AS initially compared with those who
had mild AR only (4.9 ± 3.8 vs 11.9 ± 2.7 years, P < .001).
Among various variables analyzed, only the presence of
mild AS at initial intervention predicted for development of
significant aortic valve disease on follow-up (risk ratio, 8.6;
95% confidence limit, 3.0-21.5; P < .001).
One patient with mild AS (plus mild AR) had infective endo-
carditis after 4 years. Endocarditis was treated successfully with
antibiotics but resulted in residual moderate-severe AR. In 3
patients there was documented recurrence of rheumatic carditis,
but the aortic valve disease remained unchanged.
A total of 23 patients underwent reoperation (Table 2) for
isolated mitral valve dysfunction (n = 13), isolated aortic valve
dysfunction (n = 4), and both mitral and aortic valve dysfunc-
tion (n = 6). Aortic valve lesions necessitating reoperation
included severe AR (n = 1), moderate-severe AS (n = 5), and
moderate-severe AS and moderate-severe AR (n = 4).
Discussion
Despite frequent occurrence of mild aortic valve disease at
the time of initial mitral valve intervention in rheumatic
patients, little is known about the fate of the aortic valve dis-
ease. Vaturi and colleagues2 have found that mild aortic valve
disease at the time of mitral valve operations rarely develops
into hemodynamically significant disease, even after a long
follow-up period. Only 15% (9/59) of their patients with mild
aortic valve disease at the initial presentation had moderate or
severe aortic valve disease over a follow-up of 1 to 33 years.
Likewise, in our experience the patients who initially had
pure mild AR rarely had significant aortic valve disease. Only
5% of the patients with initial mild AR had moderate or
severe AR/AS after an interval of 9 to 17 years (mean, 12.1 ±
2.8 years), and freedom from moderate or severe AR/AS was
87.4% ± 4.6% at 15 years. In contrast to this, patients who
initially had mild AS (with or without AR) had moderate-
severe aortic valve disease quite frequently. About 35%
(17/52) of patients with initial AS (with or without AR) had
moderate-severe aortic valve disease at a much shorter inter-
Figure 1. Probability of freedom (Kaplan-Meier) from moderate or severe aortic valve disease in patients who
initially had mild AS (with or without AR) or pure mild AR.
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val (range, 1–13 years; mean, 4.9 ± 3.8 years), and freedom
from moderate or severe AR/AS was 46.1% ± 11.2% at 15
years. In our experience freedom from development of mod-
erate-severe aortic valve disease in patients who initially had
mild AS was significantly less than in those who had pure
mild AR initially (Figure 1). If the experience of Vaturi and
colleagues is analyzed separately for mild AS and mild AR,
40% (3/7) of patients with initial mild AS (with or without
AR) had moderate-severe AS or AR.
Very little information is available about progression of
rheumatic AS. Most of the available reports discuss the nat-
ural history of congenital or degenerative AS. Rates of pro-
gression of mild AS are neither uniform nor predictable.8
Serial assessment in various studies have shown no progres-
sion in some patients, with variable progression ranging
from 0.1 to 0.3 cm2 per year decrease in valve area in oth-
ers.9-17 Thus, usually the progression of AS is slow, but in
certain patients it may be remarkably rapid. Investigators
have found progression of AS from the mild to the severe
form in as little as 2 to 3 years.10,13,18 Likewise, in our
patients the AS progressed rapidly. This may be attributed to
the younger age of our patients (mean, 23.5 years) in whom
rheumatic heart disease follows a more aggressive course.
In our experience, at the time of initial evaluation, severi-
ty of AS was merely assessed by gradients across the aortic
valve. No consideration was given to the aortic valve area. In
the presence of severe mitral valve disease, the hemodynam-
ic effects of AS remain masked,19-24 and thus the measured
gradients may have underestimated the severity of AS. In
such conditions calculation of valve area in relation to car-
diac output would have been a better index of severity of AS.
The aortic valve area in adults is about 3.0 cm2 (range,
2.6-3.6 cm2), and a gradient becomes detectable only when
the valve area becomes less than 2.0 cm2.8 Thus, there is a
significant decrease in aortic valve area before gradients
become detectable.25 This represents advanced commissural
fusion and valve deformity. This is in contrast to the presence
of mild AR, which can occur even with slight deformity of
one or more leaflets. Thus, the presence of mild AS signifies
a greater degree of aortic valve disease than that of mild AR.
Furthermore, turbulence caused by a stenotic valve may con-
tribute to further leaflet damage and thus may lead to rapid
progression of the disease.
Considering the drawbacks of double-valve replacement
over mitral valve replacement alone, prophylactic aortic
valve replacement may not be recommended for mild aortic
valve disease. At the same time, patients with mild AS at the
initial presentation should be considered potential candidates
for rapid progression of aortic valve disease, and a closer fol-
low-up is advised. However, these results were obtained in
patients with rheumatic valvular disease, and hence these
may not be generalized to patients with isolated aortic valve
disease of other causes.
We thank Mr Rajvir Singh, MSc (Stat), for statistical analysis.
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